Teri L. Lawver

Insider Reports History

Entity
Individual
Location
C/O Dexcom, Inc., 6340 Sequence Drive, San Diego, CA
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Teri L. Lawver:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DEXCOM INC EVP Chief Commercial Officer Common Stock 66.6K $8.96M $134.41 Mar 12, 2024 Direct
Altimmune, Inc. Director Stock Options (option to buy) 69.8K Feb 24, 2025 Direct

Insider Reports Filed by Teri L. Lawver

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALT Altimmune, Inc. Feb 24, 2025 1 $0 4 Feb 26, 2025 Director
ALT Altimmune, Inc. Feb 24, 2025 0 $0 3 Feb 26, 2025 Director
DXCM DEXCOM INC Mar 12, 2024 1 -$640K 4 Mar 14, 2024 EVP Chief Commercial Officer
DXCM DEXCOM INC Mar 8, 2024 1 $0 4 Mar 11, 2024 EVP Chief Commercial Officer
DXCM DEXCOM INC Mar 8, 2023 1 $45.40 4 Mar 10, 2023 EVP Chief Commercial Officer
DXCM DEXCOM INC Jan 9, 2023 0 $0 3 Jan 9, 2023 EVP Chief Commercial Officer